Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

NCT00834106 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3006

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV Infections

Interventions

BIOLOGICAL: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine
BIOLOGICAL: Comparator: placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC